The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oppenheimer-Marks, N.
Right arrow Articles by Lipsky, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oppenheimer-Marks, N.
Right arrow Articles by Lipsky, P. E.

The Journal of Immunology, Vol 145, Issue 1 140-148, Copyright © 1990 by American Association of Immunologists


ARTICLES

Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell

N Oppenheimer-Marks, LS Davis and PE Lipsky
Harold C. Simmons Arthritis Research Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.

An in vitro model of T cell adhesion to human umbilical vein endothelial cells (HUVEC) and transendothelial migration was used to determine whether the activation state of the T cell or cytokine exposure of the HUVEC altered T cell-HUVEC interactions or receptor utilization. Stimulation of T cells with the activator of protein kinase C, phorbol dibutyrate (PDB) alone or in combination with the calcium ionophore, ionomycin increased their binding to HUVEC. Much of the binding of control and activated T cells to HUVEC was mediated by leukocyte function-associated Ag-1 (LFA-1) (CD11a/CD18), because mAb to either chain of this molecule inhibited binding substantially, but not completely. Activation of HUVEC with IL-1 also increased binding of T cells. Binding of control T cells to IL-1-stimulated HUVEC, however, was found to be LFA-1 independent, because mAb to CD11a/CD18 failed to block the interaction. In contrast, binding of activated T cells to IL- 1-stimulated HUVEC was partially inhibited by mAb to LFA-1. Binding of activated T cells to IL-1-stimulated HUVEC also involved CD44 because this interaction was partially blocked by mAb to this determinant. When T cell migration was analyzed, it was found that the migration of PDB- activated T cells was three to four-fold more than that of control T cells. Migration through HUVEC and random migration were both enhanced by PDB stimulation. However, when the T cells were costimulated with PDB and ionomycin, migration was not increased above that of control T cells. PDB-activated T cells appeared to use LFA-1 for migration regardless of the activation status of the HUVEC, because mAb to CD11a/CD18 partially blocked their migration after binding to HUVEC. There was also a modest inhibition of PDB-activated T cell migration by mAb to CD44. In contrast, migration of control T cells involved neither LFA-1 nor CD44. Finally, binding of control T cells to high endothelial venules of peripheral lymphoid tissue was found to be CD11a/CD18 and CD44 independent, and completely inhibited by activation with either PDB or the combination of PDB and ionomycin. These results demonstrate that T cells use LFA-1 and CD44 as well as other as yet unidentified adhesion receptors for interactions with HUVEC, and that use of these adhesion receptors is mutable and related to the activation state of the T cell and cytokine stimulation of the HUVEC.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
B. Bahbouhi, L. Berthelot, S. Pettre, L. Michel, S. Wiertlewski, B. Weksler, I.-A. Romero, F. Miller, P.-O. Couraud, S. Brouard, et al.
Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line
J. Leukoc. Biol., November 1, 2009; 86(5): 1049 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. M. McGettrick, K. Hunter, P. A. Moss, C. D. Buckley, G. E. Rainger, and G. B. Nash
Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration
J. Leukoc. Biol., January 1, 2009; 85(1): 98 - 107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-N. Chen, S.-F. Chang, P.-L. Lee, K. Chang, L.-J. Chen, S. Usami, S. Chien, and J.-J. Chiu
Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow
Blood, March 1, 2006; 107(5): 1933 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G H Stummvoll, M Aringer, J Grisar, C W Steiner, J S Smolen, R Knobler, and W B Graninger
Increased transendothelial migration of scleroderma lymphocytes
Ann Rheum Dis, May 1, 2004; 63(5): 569 - 574.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Greenwood, C. L. Amos, C. E. Walters, P.-O. Couraud, R. Lyck, B. Engelhardt, and P. Adamson
Intracellular Domain of Brain Endothelial Intercellular Adhesion Molecule-1 Is Essential for T Lymphocyte-Mediated Signaling and Migration
J. Immunol., August 15, 2003; 171(4): 2099 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. R. Alevriadou
CAMs and Rho small GTPases: gatekeepers for leukocyte transendothelial migration. Focus on "VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration"
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C250 - C252.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Tay, A. McCormack, C. Lawson, and M. L. Rose
IFN-{gamma} Reverses the Stop Signal Allowing Migration of Antigen-Specific T Cells into Inflammatory Sites
J. Immunol., March 15, 2003; 170(6): 3315 - 3322.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Amos, I. A. Romero, C. Schultze, J. Rousell, J. D. Pearson, J. Greenwood, and P. Adamson
Cross-Linking of Brain Endothelial Intercellular Adhesion Molecule (ICAM)-1 Induces Association of ICAM-1 With Detergent-Insoluble Cytoskeletal Fraction
Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 810 - 816.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Faveeuw, M. E. Di Mauro, A. A. Price, and A. Ager
Roles of {alpha}4 integrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial migration of T lymphocytes and T lymphoblasts across high endothelial venules
Int. Immunol., March 1, 2000; 12(3): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kawakami, F. Nishizawa, N. Sakane, M. Iwao, K. Tsujikawa, M. Ikawa, M. Okabe, and H. Yamamoto
Roles of Integrins and CD44 on the Adhesion and Migration of Fetal Liver Cells to the Fetal Thymus
J. Immunol., September 15, 1999; 163(6): 3211 - 3216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Haque Gazi and M. Ito
Use of A Novel Fibronectin Receptor for Liver Infiltration by a Mouse Lymphoma Cell Line RL-{}1
Cancer Res., March 1, 1999; 59(5): 1115 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Adamson, S. Etienne, P.-O. Couraud, V. Calder, and J. Greenwood
Lymphocyte Migration Through Brain Endothelial Cell Monolayers Involves Signaling Through Endothelial ICAM-1 Via a Rho-Dependent Pathway
J. Immunol., March 1, 1999; 162(5): 2964 - 2973.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. I. Brezinschek, N. Oppenheimer-Marks, and P. E. Lipsky
Activated T Cells Acquire Endothelial Cell Surface Determinants During Transendothelial Migration
J. Immunol., February 1, 1999; 162(3): 1677 - 1684.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Gerli, C. Paolucci, P. Gresele, O. Bistoni, S. Fiorucci, C. Muscat, S. Belia, A. Bertotto, and V. Costantini
Salicylates Inhibit Adhesion and Transmigration of T Lymphocytes by Preventing Integrin Activation Induced by Contact With Endothelial Cells
Blood, October 1, 1998; 92(7): 2389 - 2398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Somersalo, O. Carpén, E. Saksela, C. G. Gahmberg, P. Nortamo, and T. Timonen
Activation of Natural Killer Cell Migration by Leukocyte Integrin-binding Peptide from Intracellular Adhesion Molecule-2 (ICAM-2)
J. Biol. Chem., April 14, 1995; 270(15): 8629 - 8636.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
H. Wakita and M. Takigawa
E-Selectin and Vascular Cell Adhesion Molecule-1 Are Critical for Initial Trafficking of Helper-Inducer/Memory T Cells in Psoriatic Plaques
Arch Dermatol, April 1, 1994; 130(4): 457 - 463.
[Abstract] [PDF]


Home page
CROBMHome page
J. M. Crawford and K. Watanabe
Cell Adhesion Molecules in Inflammation and Immunity: Relevance to Periodontal Diseases
Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(2): 91 - 123.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
C. N. Bertolami and D. V. Messadi
The Role of Proteoglycans in Hard and Soft Tissue Repair
Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(3): 311 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H Hourihan, T. Allen, and A Ager
Lymphocyte migration across high endothelium is associated with increases in alpha 4 beta 1 integrin (VLA-4) affinity
J. Cell Sci., January 4, 1993; 104(4): 1049 - 1059.
[Abstract] [PDF]


Home page
ScienceHome page
A. Huber, S. Kunkel, R. Todd 3rd, and S. Weiss
Regulation of transendothelial neutrophil migration by endogenous interleukin-8
Science, October 4, 1991; 254(5028): 99 - 102.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.